| Global Renal Cell Carcinoma (RCC) Drugs Market to Reach $3.03 Billion by 2017 ... - San Francisco Chronicle (press release) |
|
|
San Francisco Chronicle (press release) Among the various types of kidney cancers, Renal Cell Carcinoma (RCC) is the predominant type of kidney cancer, accounting for about 90% of all kidney cancers. Key factors driving market growth include increase in treatment rate and diagnosed incidence |